DD138600A5 - Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes - Google Patents

Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes

Info

Publication number
DD138600A5
DD138600A5 DD78208003A DD20800378A DD138600A5 DD 138600 A5 DD138600 A5 DD 138600A5 DD 78208003 A DD78208003 A DD 78208003A DD 20800378 A DD20800378 A DD 20800378A DD 138600 A5 DD138600 A5 DD 138600A5
Authority
DD
German Democratic Republic
Prior art keywords
prostacyclin
cyclodextrins
preparing
inclusion complex
complex made
Prior art date
Application number
DD78208003A
Other languages
German (de)
English (en)
Inventor
Jozsef Szejtli
Magdolna Szejtli
Gyoergy Cseh
Istvan Stadler
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DD138600A5 publication Critical patent/DD138600A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD78208003A 1977-09-23 1978-09-21 Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes DD138600A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (ru) 1977-09-23 1977-09-23

Publications (1)

Publication Number Publication Date
DD138600A5 true DD138600A5 (de) 1979-11-14

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78208003A DD138600A5 (de) 1977-09-23 1978-09-21 Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes

Country Status (20)

Country Link
JP (1) JPS5456685A (ru)
AT (1) AT369362B (ru)
BE (1) BE870646A (ru)
CH (1) CH637388A5 (ru)
CS (1) CS200242B2 (ru)
DD (1) DD138600A5 (ru)
DE (1) DE2840142A1 (ru)
DK (1) DK420778A (ru)
FI (1) FI65912C (ru)
FR (1) FR2404006A1 (ru)
GB (1) GB2006193B (ru)
GR (1) GR65001B (ru)
HU (1) HU179141B (ru)
IL (1) IL55569A (ru)
IT (1) IT1160661B (ru)
NL (1) NL7809643A (ru)
PL (1) PL121664B1 (ru)
SE (1) SE447574B (ru)
SU (1) SU847914A3 (ru)
YU (1) YU220678A (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
WO2005073223A1 (ja) 2004-01-29 2005-08-11 Eisai R & D Management Co., Ltd. マクロライド系化合物の安定化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (ru) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
GB2006193A (en) 1979-05-02
YU220678A (en) 1983-10-31
PL121664B1 (en) 1982-05-31
CH637388A5 (de) 1983-07-29
FI65912C (fi) 1984-08-10
BE870646A (fr) 1979-01-15
JPS5456685A (en) 1979-05-07
HU179141B (ru) 1982-08-28
IT7869160A0 (it) 1978-09-19
FI782878A (fi) 1979-03-24
SE447574B (sv) 1986-11-24
ATA677478A (de) 1982-05-15
AT369362B (de) 1982-12-27
SE7809946L (sv) 1979-03-24
DK420778A (da) 1979-03-24
NL7809643A (nl) 1979-03-27
SU847914A3 (ru) 1981-07-15
FR2404006A1 (fr) 1979-04-20
GR65001B (en) 1980-06-12
FI65912B (fi) 1984-04-30
IT1160661B (it) 1987-03-11
FR2404006B1 (ru) 1981-07-31
PL209773A1 (pl) 1979-06-04
IL55569A (en) 1981-12-31
CS200242B2 (en) 1980-08-29
DE2840142A1 (de) 1979-04-05
IL55569A0 (en) 1978-12-17
GB2006193B (en) 1982-05-26

Similar Documents

Publication Publication Date Title
DD132052A5 (de) Verfahren zur herstellung eines katalysators
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
AT386228B (de) Verfahren zur herstellung eines kunststoff-maschengebildes
ATA971776A (de) Verfahren zur herstellung eines stabilen antibiotischen praparates
AT362082B (de) Verfahren zur herstellung eines desinfektions- mittels
LU79519A1 (de) Verfahren zur herstellung eines wachstumsfoerdernden mittels
AT355523B (de) Verfahren zur herstellung eines gurtbandes
DD135495A5 (de) Verfahren zur herstellung eines wasserunloeslichen enzympraeparats
AT373853B (de) Verfahren zur herstellung eines katalysatortraegers
AT373854B (de) Verfahren zur herstellung eines katalysatortraegers
AT357407B (de) Verfahren zur herstellung eines speckaehnlichen produktes
ATA595778A (de) Verfahren zur herstellung eines nahrungsmittels
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
AT360512B (de) Verfahren zur herstellung eines d-enantiomeren indolderivats
DD138600A5 (de) Verfahren zur herstellung eines mit cyclodextrinen gebildeten prostacyclin-einschlusskomplexes
ATA499079A (de) Verfahren zur herstellung eines synthetischen crepegarns
DD134098A5 (de) Verfahren zur herstellung eines 9-hydroxyaethoxymethylguanin-derivats
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT367071B (de) Verfahren zur herstellung eines katalysators
AT357855B (de) Verfahren zur herstellung eines pektin- praeparates
ATA136678A (de) Verfahren zur herstellung eines neuen morphanderivates
DD129802A1 (de) Verfahren zur herstellung eines farblosen xanthomonas-polysaccharides
AT361527B (de) Verfahren zur herstellung eines verbundwerk- stoffes
DD131714A1 (de) Verfahren zur herstellung eines nahrungsfettes
DD129900A5 (de) Verfahren zur herstellung eines spasmolytikums